Organization
Bedford Laboratories, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Bedford Laboratories, Inc.
... performing well. We are making good progress transferring the products acquired from Bedford Laboratories to our manufacturing facilities in New Jersey, Germany and Portugal and ...
... assets from Boehringer Ingelheim, following its agreement to purchase the assets of Bedford Laboratories. Under the terms of the agreement announced today, Xellia has acquired ...
... phentolamine blocking test. Phentolamine will be the third product previously marketed by Bedford Laboratories to be launched by Hikma in the US, and is the ...
... phentolamine blocking test. Phentolamine will be the third product previously marketed by Bedford Laboratories to be launched by Hikma in the United States, and is ...
... breast and ovary. It will be the second product previously marketed by Bedford Laboratories to be launched by Hikma in the US. Said Darwazah, Chairman ...
... Hikma said, 'We are making good progress with the transfer of the Bedford products to our manufacturing facilities, leveraging our strong R&D, regulatory and manufacturing ...
... other products. We are making good progress transferring the products acquired from Bedford Laboratories in 2014 to our manufacturing facilities in New Jersey, Germany and ...
... Invests in Generic Injectable Drug Services Company: Health Care Firm Recruits Former Bedford Laboratories Executive to Spearhead Custopharm's Growth Water Street Healthcare Partners, a strategic ...
... Stanleyhad been tapped to run the auction. Boehringer last year sold its Bedford Laboratories U.S. injectable generics unit after the Food and Drug Administration closed ...
... the help of deals such as last July's $300m acquisition of US-based Bedford Laboratories from Boehringer Ingelheim of Germany. Analysts have estimated that Hikma has ...
... could affect the integrity of the container closure. Boehringer Ingelheim closed the Bedford, OH, site at the end of last year and laid off about ...
... agreed to sell Jordan's Hikma its generic injectable business sold under its Bedford Laboratories brand, for $300 million in cash and milestones. Then last month, ...
... deal with Boehringer Ingelheim's Ben Venue Laboratories group to buy assets of Bedford Laboratories, its generic injectable drug unit. Hikma will pay $225 million up ...
... Mergers and Acquisitions . TARGET COMPANY: 2392540 Bedford Laboratories SELLERS: 1973210 Boehringer Ingelheim GmbH ACQUIRER COMPANY: 2044370 Hikma Pharmaceuticals plc ...
Subscribe now for full coverage on Bedford Laboratories, Inc.
Start My Free Trial